Takeda’s Bitetti sells 46,609 depositary shares

Q: How many TAK shares did Teresa Marie Bitetti hold after the sale?

Her reported direct holdings after the sale were 214,501 American Depositary Shares. That amount includes 9,100 ADS received upon vesting of dividend equivalent units that were not included in her previously filed Form 4.

The reported post-sale position includes 9,100 ADS received upon vesting of dividend equivalent units omitted from an earlier Form 4.

Available on EDGAR 11/04/2026 - 05:36 PM EST Accepted by SEC EDGAR 11/04/2026 - 05:35 PM EST

Filing Impact

(Neutral)

Filing Sentiment

(Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Takeda Pharmaceutical Co Ltd President, OBU, Teresa Marie Bitetti sold 46,609 American Depositary Shares on November 2, 2026, at $20.89 per share. Her reported direct holdings after the sale were 214,501 American Depositary Shares, including 9,100 ADS received upon vesting of dividend equivalent units that were not included in her previously filed Form 4. No Rule 10b5-1 plan is reported for the transaction.

Insider Trade Summary

Net Seller: 46,609 shares

Net Sell 1 txn

Insider Bitetti Teresa Marie

Role President, OBU

Sold 46,609 shs ($974K)

Type	Security	Shares	Price	Value
Sale	American Depositary Shares ^F1	46,609	$20.89	$974K

Holdings After Transaction: American Depositary Shares — 214,501 shares (Direct)

Footnotes (1)

F1. Includes 9,100 ADS received upon the vesting of dividend equivalent units that were not included in the reporting person's previously filed Form 4.

Key Figures

American Depositary Shares sold: 46,609 American Depositary Shares Sale price: $20.89 per share Direct holdings after transaction: 214,501 American Depositary Shares +1 more

4 metrics

American Depositary Shares sold 46,609 American Depositary Shares November 2, 2026

Sale price $20.89 per share November 2, 2026

Direct holdings after transaction 214,501 American Depositary Shares Reported after the sale on November 2, 2026

ADS received upon vesting 9,100 ADS Included in reported post-transaction holdings; not included in a previously filed Form 4

Key Terms

American Depositary Shares, dividend equivalent units, Rule 10b5-1 plan

3 terms

American Depositary Shares financial

"security title: American Depositary Shares"

American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

dividend equivalent units financial

"received upon the vesting of dividend equivalent units"

Dividend equivalent units are bookkeeping credits that mirror cash dividends paid on actual shares, granted to holders of stock-based awards such as restricted stock units or deferred compensation. They matter to investors because they increase a company’s reported employee compensation cost and can lead to issuance of more shares or cash payouts over time, similar to extra pay linked to ownership that affects shareholder dilution and corporate cash flow.

Rule 10b5-1 plan financial

"No Rule 10b5-1 plan is reported for the transaction"

A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many TAK shares did Teresa Marie Bitetti sell, and at what price?

Takeda Pharmaceutical Co Ltd President, OBU, Teresa Marie Bitetti sold 46,609 American Depositary Shares on November 2, 2026, at $20.89 per share. No Rule 10b5-1 plan is reported for the transaction.

How many TAK shares did Teresa Marie Bitetti hold after the sale?

Her reported direct holdings after the sale were 214,501 American Depositary Shares. That amount includes 9,100 ADS received upon vesting of dividend equivalent units that were not included in her previously filed Form 4.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bitetti Teresa Marie

(Last)

(First)

(Middle)

40 LANDSDOWNE STREET

(Street)

CAMBRIDGE

MASSACHUSETTS

02139

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
TAKEDA PHARMACEUTICAL CO LTD [ TAK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	President, OBU

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
American Depositary Shares	11/02/2026		S		46,609	D	$20.89	214,501⁽¹⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Includes 9,100 ADS received upon the vesting of dividend equivalent units that were not included in the reporting person's previously filed Form 4.

	/s/ Kate Huleatt, by power of attorney, for Teresa Bitetti	11/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR